It further proved whether SBF2-AS1 could regulate miR-520a-3p expression to mediate the NSCLC cells malignant biological behavior, thereby revealing the mechanism of NSCLC progression and providing new targets for NSCLC-targeted therapy and research directions. The gene discussed is SBF2; the disease is non-small cell lung carcinoma.